"The Berlin universities are excellent and have won the German competition! We at the MDC congratulate our partners, the three universities and the Charité. We are extremely pleased that top-level research in Berlin can now be expanded even further," said Thomas Sommer, Scientific Director (interim) of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC).
"The decision is an important signal for our city. The science metropolis of Berlin, with its excellent universities and many renowned research institutions, is now becoming even more attractive. It can develop a pull for talents and young researchers from all over the world. It shows how valuable and rewarding it is to work well together and join forces instead of competing as a lone fighter. ‘Crossing boundaries’ was the motto of the successful Berlin University Alliance. It spurs us all on, the entire research landscape in Berlin," said Sommer.
The MDC is one of the world's leading biomedical research centers, attracting talent from all over the world - about half the researchers are from foreign countries. This expertise in basic research and translation flows into Berlin's universities and Charité in many ways. For example, most professors at the MDC also hold a chair at a Berlin university. The MDC, along with the, is part of the Neurocure Cluster of Excellence, involved in Math+, and participates in numerous graduate schools.
Max Delbrück Center for Molecular Medicine in the Helmholtz Association
Head of the Communications Department
Phone: +49 30 9406 2140